MedTrace Logo

Automated Quantification of Radiologic Pulmonary Alteration During Acute Respiratory Failure

NCT04534400 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2023-04-18

No results posted yet for this study

Summary

Automated quantification of the pulmonary volume impaired during acute respiratory failure could be helpful to assess patient severity during COVID-19 infection or perioperative medicine, for example.

This study aim at assessing the correlation between the amount of radiologic pulmonary alteration and the clinical severity in two clinical situation :

1. SARS-CoV-2 infections
2. Postoperative hypoxemic acute respiratory failure

Conditions

Interventions

RADIATION

thoracic CT-scan

Automated measurement

Sponsors & Collaborators

  • VISIBLE PATIENT, E-MEDIA

    collaborator UNKNOWN

  • University Hospital, Strasbourg, France

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2024-03-01
Completion
2024-03-01

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04534400 on ClinicalTrials.gov